Evangelia Sereti

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsRegolith and landscape evolutionRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 17, 2026
Combination of PARP inhibitor olaparib and a vascular disrupting agent reduces tumor growth in a preclinical model of prostate cancer.

|Jun 29, 2026
Restriction-Weighted Q-Space Trajectory Imaging (ResQ): Toward Mapping Diffusion-Time Effects With Tensor-Valued Diffusion Encoding in Human Prostate Cancer Xenografts.

|Oct 29, 2025
Novel 1-(2-Aryl-2-adamantyl)piperazine Derivatives Exhibit In Vitro Anticancer Activity Across Various Human Cancer Cell Lines, with Selective Efficacy Against Melanoma.

Irida Papapostolou, Evangelia Sereti, Stavroula Chatira

|Jul 25, 2024
Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting.

Daniel Roth, Marcella Safi, Oskar Vilhelmsson Timmermand

|Mar 29, 2023
Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?

Evangelia Sereti, Irida Papapostolou, Konstantinos Dimas

|Feb 25, 2023
Increased Expression of the Mitochondrial Glucocorticoid Receptor Enhances Tumor Aggressiveness in a Mouse Xenograft Model.

Aikaterini G Karra, Ioannis Tsialtas, Foteini D Kalousi

Pageof 1

Frequent Collaborators

2 joint publications

Irida Papapostolou

2 joint publications

Konstantinos Dimas

2 joint publications

Malwina Molendowska

2 joint publications

Filip Szczepankiewicz